Long term hormone therapy for perimenopausal and postmenopausal women
J Marjoribanks, C Farquhar, H Roberts… - … of systematic reviews, 2012 - cochranelibrary.com
Background Hormone therapy (HT) is widely used for controlling menopausal symptoms
and has also been used for the management and prevention of cardiovascular disease …
and has also been used for the management and prevention of cardiovascular disease …
Postmenopausal hormone therapy: an Endocrine Society scientific statement
Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …
Fixed effects analysis of repeated measures data
FI Gunasekara, K Richardson, K Carter… - International journal of …, 2014 - academic.oup.com
The analysis of repeated measures or panel data allows control of some of the biases which
plague other observational studies, particularly unmeasured confounding. When this bias is …
plague other observational studies, particularly unmeasured confounding. When this bias is …
Hormone therapy for preventing cardiovascular disease in post‐menopausal women
HMP Boardman, L Hartley, A Eisinga… - Cochrane database …, 2015 - cochranelibrary.com
Background Evidence from systematic reviews of observational studies suggests that
hormone therapy may have beneficial effects in reducing the incidence of cardiovascular …
hormone therapy may have beneficial effects in reducing the incidence of cardiovascular …
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health
TJ De Villiers, A Pines, N Panay, M Gambacciani… - …, 2013 - Taylor & Francis
Ten years after the first results from the Women's Health Initiative (WHI) trial were published,
it seems that the atmosphere around the issue of menopausal hormone therapy (MHT) is …
it seems that the atmosphere around the issue of menopausal hormone therapy (MHT) is …
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
C Renoux, S Dell'Aniello, E Garbe, S Suissa - Bmj, 2010 - bmj.com
Objectives To determine the risk of stroke associated with oral and transdermal routes of
administration of hormone replacement therapy. Design Population based nested case …
administration of hormone replacement therapy. Design Population based nested case …
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health
DW Sturdee, A Pines… - …, 2011 - Taylor & Francis
The past decade has seen marked fluctuations in opinions concerning the merits and risks
of postmenopausal hormone replacement therapy (HRT). In July 2002, menopause …
of postmenopausal hormone replacement therapy (HRT). In July 2002, menopause …
[图书][B] A biologia da crença
BH Lipton - 2022 - books.google.com
Bruce H. Lipton tinha sete anos quando pela primeira vez pôs os olhos num microscópio.
Foi amor à primeira vista. Anos mais tarde, já professor de Medicina na Universidade do …
Foi amor à primeira vista. Anos mais tarde, já professor de Medicina na Universidade do …
Stroke risk in women: the role of menopause and hormone therapy
L Lisabeth, C Bushnell - The Lancet Neurology, 2012 - thelancet.com
Although women have a lower risk of stroke during middle age than men, the menopausal
transition is a time when many women develop cardiovascular risk factors. Additionally …
transition is a time when many women develop cardiovascular risk factors. Additionally …
Potential new risk factors for ischemic stroke: what is their potential?
GJ Hankey - Stroke, 2006 - Am Heart Assoc
Background and Purpose—About 60% to 80% of all ischemic strokes can be attributed to
increasing blood pressure, blood cholesterol, cigarette smoking, carotid stenosis, and …
increasing blood pressure, blood cholesterol, cigarette smoking, carotid stenosis, and …